Previous 10 | Next 10 |
Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today report...
BioTelemetry (NASDAQ: BEAT ) is scheduled to announce Q4 earnings results on Wednesday, February 26th, after market close. The consensus EPS Estimate is $0.27 (-51.8% Y/Y) and the consensus Revenue Estimate is $110.18M (+6.4% Y/Y). Over the last 2 years, BEAT has beaten EPS estimates ...
MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2020....
"I love riding a horse that's running." - David Tepper ( CNBC , 1/17/2020) Seasonal tendencies continue to dominate, overshadowing ongoing elevated readings that are historically coincident with overbought markets. For example, 48.74% of stocks in our ~1,600 stock universe are currently ...
Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Investment Thesis I last wrote about BioTelemetry ( BEAT ) at the end of May. At that time the share price had fallen sharply from a February high of $75 to just over $48. It seems likely that BioTel's share price had risen thanks to a collaboration with Apple Health. Apple ( AAPL ) wanted...
BioTelemetry, Inc. (BEAT) Q3 2019 Earnings Conference Call November 05, 2019 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial Officer Conference Call Participants Brooks O'Neil – Lake Str...
BioTelemetry (NASDAQ: BEAT ): Q3 Non-GAAP EPS of $0.52 beats by $0.04 ; GAAP EPS of $0.23 misses by $0.12 . Revenue of $111.3M (+11.3% Y/Y) in-line. Press Release More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news,
Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of car...
MALVERN, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, November 5, 2019. The br...
News, Short Squeeze, Breakout and More Instantly...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has been added to the Russell Microcap(R) Index. The move was effective after market close on June 28, 2024, and is part of FTSE Russell’s annual reconst...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced that it has been added to the Russell Microcap® Index effective after the market close on June 28, 2024 as part of FTSE Russell...
HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced the results of a new study demonstrating that HeartBeam AI combined with vectorcardiography (“VCG”) outperformed an expert panel o...